Edité par LAP LAMBERT Academic Publishing Sep 2023, 2023
ISBN 10 : 620678651X ISBN 13 : 9786206786511
Langue: anglais
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
EUR 60,90
Quantité disponible : 2 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Neuware -For UV protection, Lutein was successfully delivered topically using gels made of nanostructured lipid carrier (NLC) technology. Drugs and their possible excipients were screened for NLC during preformulation studies using methods such organoleptic assessment, melting point analysis, UV-Visible spectra, solubility studies, partition coefficient, and Fourier transform-Infrared (FT-IR) analysis.After the drug was successfully characterized, formulation development was carried out to select and optimize solid and liquid lipid, solid lipid to liquid lipid ratio, surfactant and co-surfactant concentrations, formulation technique, and process factors i.e. stirring speed, stirring time, and homogenization cycles. Following the optimization of process parameters, a formulation table was created and NLC were produced appropriately. In order to develop the optimal NLC formulation, the characterizations of the produced NLC formulations were assessed for shape and surface morphology (TEM), particle size, zeta potential , % entrapment efficiency, and in vitro release testing.The optimized Lutein NLC formulation has a particle size of 81.64 nm, a zeta potential of -14.1 mV.Books on Demand GmbH, Überseering 33, 22297 Hamburg 104 pp. Englisch.
Edité par LAP LAMBERT Academic Publishing Sep 2023, 2023
ISBN 10 : 620678651X ISBN 13 : 9786206786511
Langue: anglais
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
EUR 60,90
Quantité disponible : 2 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -For UV protection, Lutein was successfully delivered topically using gels made of nanostructured lipid carrier (NLC) technology. Drugs and their possible excipients were screened for NLC during preformulation studies using methods such organoleptic assessment, melting point analysis, UV-Visible spectra, solubility studies, partition coefficient, and Fourier transform-Infrared (FT-IR) analysis.After the drug was successfully characterized, formulation development was carried out to select and optimize solid and liquid lipid, solid lipid to liquid lipid ratio, surfactant and co-surfactant concentrations, formulation technique, and process factors i.e. stirring speed, stirring time, and homogenization cycles. Following the optimization of process parameters, a formulation table was created and NLC were produced appropriately. In order to develop the optimal NLC formulation, the characterizations of the produced NLC formulations were assessed for shape and surface morphology (TEM), particle size, zeta potential , % entrapment efficiency, and in vitro release testing.The optimized Lutein NLC formulation has a particle size of 81.64 nm, a zeta potential of -14.1 mV. 104 pp. Englisch.
Edité par LAP LAMBERT Academic Publishing, 2023
ISBN 10 : 620678651X ISBN 13 : 9786206786511
Langue: anglais
Vendeur : moluna, Greven, Allemagne
EUR 47,68
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: SHARMA BHAWNAMs. BHAWNA SHARMA has completed M.Pharm from Dr. APJ Abdul Kalam Technical University. Currently, She is working as Assistant Professor in Dr. K. N. Modi Institute of Pharmaceutical Education &Research, Modinagar, Ghazia.
Edité par LAP LAMBERT Academic Publishing, 2023
ISBN 10 : 620678651X ISBN 13 : 9786206786511
Langue: anglais
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
EUR 61,63
Quantité disponible : 1 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - For UV protection, Lutein was successfully delivered topically using gels made of nanostructured lipid carrier (NLC) technology. Drugs and their possible excipients were screened for NLC during preformulation studies using methods such organoleptic assessment, melting point analysis, UV-Visible spectra, solubility studies, partition coefficient, and Fourier transform-Infrared (FT-IR) analysis.After the drug was successfully characterized, formulation development was carried out to select and optimize solid and liquid lipid, solid lipid to liquid lipid ratio, surfactant and co-surfactant concentrations, formulation technique, and process factors i.e. stirring speed, stirring time, and homogenization cycles. Following the optimization of process parameters, a formulation table was created and NLC were produced appropriately. In order to develop the optimal NLC formulation, the characterizations of the produced NLC formulations were assessed for shape and surface morphology (TEM), particle size, zeta potential , % entrapment efficiency, and in vitro release testing.The optimized Lutein NLC formulation has a particle size of 81.64 nm, a zeta potential of -14.1 mV.